TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic scientists in advancing novel compounds through the drug development process. Launched in June 2022, TRxA is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics, from the lab to patientsContinue reading
Category Archives: AZBio News
New Data Predicts Impacts of the IRA on the Health Innovation Ecosystem
This Vital Health Podcast was recorded at the BIO international Conference on the afternoon of the release of Vital Transformation’s research study outlining the impacts of the Inflation Reduction Act on U.S. biopharma innovation. It features Duane Schulthess, Nick Shipley, the Executive Vice President of BIO, and Joe Hammang, Vital Transformation’s U.S. Business Director.Continue reading
Call for Abstracts: Arizona Alzheimer’s Consortium 2023 Annual Scientific Conference
The Arizona Alzheimer’s Consortium 2023 Annual Scientific Conference will be held Monday, September 11, 2023 from 8:45am – 3:45pmat
Arizona State University in Tempe. Continue reading
Langham Upgrades Phoenix GMP Warehouse, CRT Expansion
INDIANAPOLIS—Langham Logistics, an Indiana-based warehousing and transportation company with a focus in life sciences, today announced an adaptation of the second half of its Arizona building to GMP controlled room space. More than 9,000 newly-converted controlled room temperature (CRT) pallet positions opened for full operations on June 1st to serve the West Coast’s cold chain warehousing and distribution demands.Continue reading
Single-Cell Atlas of the Whole Human Lung
First integrated Human Lung Cell Atlas provides insights into lung diseases.
By combining data from nearly 40 studies, an international team of researchers, including TGen’s Dr. Nicholas Banovich, created the first integrated single-cell atlas of the lung, revealing rare cell types and highlighting cellular differences between healthy people. In addition, the study found common cell states between lung fibrosis, cancer and COVID-19, offering new ways of understanding lung disease, which could help identify new therapeutic targets.
C-Path’s Integrated Clinical Trial Database to Help Advance Research in Parkinson’s
TUCSON, Ariz., June 20, 2023 — Critical Path Institute (C-Path), an independent nonprofit organization, today announced it is providing access to the Critical Path for Parkinson’s (CPP) Integrated Parkinson’s Database to external qualified researchers.Continue reading
CSL Behring Announces the First Patient Has Received FDA-Approved HEMGENIX® (etranacogene dezaparvovec-drlb) for Hemophilia B
HEMGENIX®, the first and only FDA approved gene therapy for hemophilia B, has been proven to elevate and sustain factor IX levels for years, significantly reduce the rate of annual bleeds versus standard of care, and reduce or eliminate the need for prophylactic treatment in 94% of patients (51 out of 54) after a one-time infusionContinue reading
ABOR approves establishment of College of Health Sciences at UArizona Health Sciences
The University of Arizona College of Health Sciences will focus on graduate programs to fill positions of need in the health care community.Continue reading
C-Path’s PSTC Receives Positive FDA Response for Drug-Induced Pancreatic Injury Biomarkers
Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical trialsContinue reading
CSBI Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention
BOSTON, MASS., U.S.A., June 7, 2023/EINPresswire.com/ — The Coalition of State Bioscience Institutes (CSBI) releases the 2023 Life Sciences Workforce Trends Report with TEConomy Partners this week at the 2023 BIO International Convention in Boston. The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.Continue reading